In addition, EVs released by epithelial ovarian cancer cell lines carrying SMAD4 mutations enhanced platinum-resistant phenotype in recipient drug-sensitive ovarian cancer cells, suggesting a possible transfer of SMAD4 mutations through EVs [97]. This evidence concerns the gene SMAD4 and ovarian carcinoma.